Clinical Trial Update: Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery

View source ↗

Summary

A clinical trial evaluating dynamic monitoring of circulating tumor DNA (ctDNA) and cfHPV DNA in plasma to predict recurrence after cervical cancer surgery, cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: The Third Affiliated Hospital of Guangzhou Medical University | Conditions: cfHPV DNA in Plasma of Cervical Cancer Patients | Status: RECRUITING